2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zoja, C. Articles by Remuzzi, G. Search for Related Content PubMed PubMed Citation Articles by Zoja, C. Articles by Remuzzi, G.

Proteinuria and Phenotypic Change of Proximal Tubular Cells

Carla Zoja^*, Marina Morigi^* and Giuseppe Remuzzi^*,

*Mario Negri Institute for Pharmacological Research, Bergamo, Italy; and Division of Nephrology and Dialysis, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy.

Correspondence to Dr. Carla Zoja, Laboratory of Experimental Models of Kidney Diseases, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy; Phone: +39-035-319-888; Fax: +39-035-319-331; E-mail: zoja{at}marionegri.it

	Introduction

Top Introduction Protein Traffic as a... Protein Uptake by Proximal... Ultrafiltered Proteins Activate... Complement as a Pathogenic... Protein Overload Activates... References

 
Terminal renal failure is the final common fate of chronic nephropathies independent of the type of initial insult. The outstanding review by Brenner et al. (1) in 1982 introduced the idea that glomerular hemodynamic changes that develop as compensatory adaptation to irreversible nephron damage cause progressive deterioration of function and structure of the remaining nephrons. After reduction of renal mass in rats, remnant intact nephrons undergo sudden hypertrophy with concomitant lowering of arteriolar resistance and increased glomerular plasma flow that results from a differential decrease in vessel tone that is less in afferent than efferent arterioles. This fosters adaptive increase in glomerular capillary hydraulic pressure and more filtrate per nephron, changes, however, that are detrimental in the long term. The increase in intraglomerular capillary pressure alters the size-selective function of the glomerular barrier and causes protein ultrafiltration.

Abnormally filtered proteins have an intrinsic renal toxicity linked to their over-reabsorption by proximal tubular cells and activation of tubular-dependent pathways of interstitial inflammation and fibrosis (2,3). The functional importance of tubulointerstitial events in progressive renal disease is supported by evidence that the severity of tubular interstitial damage strongly correlates with the risk of renal failure, even better than do the glomerular lesions. The relationship between proteinuria and tubulointerstitial damage was suggested by early studies in renal biopsies of rats with age-related proteinuria (4) and adriamycin nephrosis (5), showing that protein reabsorption droplets accumulate in the cytoplasm of proximal tubular cells with focal breaks of the tubular basement membrane and extravasation of the tubular content into the renal interstitium, followed by an inflammatory reaction and tubulointerstitial lesions. Furthermore, in models of overload proteinuria, repeated injections of albumin in the rat increased glomerular barrier permeability and caused massive proteinuria (6,7) and tubular changes with heavy macrophage and T-lymphocyte infiltration into the renal interstitium (8). That excess protein reabsorption by proximal tubular cells may play a role in the development of interstitial inflammation has been documented by a recent study of our group in two different models of proteinuric nephropathies (9). In rats with 5/6 nephrectomy, albumin and IgG accumulation in proximal tubular cells was visualized in the early stage, preceding the interstitial infiltration of major histocompatability complex II–positive cells and macrophages. The infiltrating cells concentrated almost exclusively in regions containing IgG-positive proximal tubules and tubules with luminal casts. Similar patterns were found in the immune model of passive Heymann nephritis indicating that the interstitial inflammatory reaction develops at the sites of protein overload, regardless of the type of glomerular injury.

	Protein Traffic as a Fosterer of Tubular Cell Dysfunction

Top Introduction Protein Traffic as a... Protein Uptake by Proximal... Ultrafiltered Proteins Activate... Complement as a Pathogenic... Protein Overload Activates... References

 
Filtered albumin and other proteins that accumulate within intracellular compartments of proximal tubular cells perturb cell function by several mechanisms. Studies have contributed to define the biochemical pathways specifically activated by excessive tubular reabsorption, and evidence is now available that protein overloading of proximal tubular cells in culture activates the transcription of a number of genes encoding for vasoactive, inflammatory, and fibrogenic molecules with potential toxic effects on the kidney.

	Protein Uptake by Proximal Tubular Cells

Top Introduction Protein Traffic as a... Protein Uptake by Proximal... Ultrafiltered Proteins Activate... Complement as a Pathogenic... Protein Overload Activates... References

 
Proteins that have not been retained by the glomerulus are reabsorbed in the proximal tubules via processes that involve binding at the apical pole of the cells, vascular internalization, and subsequent lysosomal degradation into constituent amino acids and small peptides. The initial recognition step by receptor-mediated endocytosis involves at least two high molecular weight proteins, megalin and cubilin, which have multiligand properties and can therefore account for the wide variety of protein reabsorbed (10). Megalin—-a transmembrane glycoprotein that belongs to the LDL receptor family—is the most abundant endocytic receptor in the proximal tubule epithelium, where it is concentrated in clathrin-coated pits and vesicles in the brush border region. It acts as a receptor for different ligands, including albumin, insulin, prolactin, and vitamin-binding proteins. Megalin’s endocytotic function is regulated by heterotrimeric G protein–internalization signals (Gi3, GAIP, and GIPC) (11) interacting with the cytoplasmic tail of megalin. This portion of the molecule also contains Src-homology domains, PDZ domains, and protein kinase phosphorylation sites, suggestive for a role of megalin in signal transduction. The potential for megalin to signal into the cell rests on the in vitro observation that the mitogenic effect of albumin in proximal tubular cells was mediated by the activation of phosphatidylinositol 3-kinase, which resulted in downstream phosphorylation and hence activation of p70 ribosomal protein S6 kinase (12,13).

Cubilin is another glycoprotein that is heavily expressed in the brush borders and intracellular endocytic compartments and that binds albumin, transferrin, IgG light chains, and receptor-associated protein (10,14,15). Cubilin is devoid of a transmembrane domain, and cubilin/ligand complexes are associated with megalin during internalization. That the cubilin internalization depends on megalin is supported by a recent report showing that cubilin-mediated endocytosis of transferrin did not operate in megalin knockout mice that excreted high amounts of transferrin (16).

	Ultrafiltered Proteins Activate Proximal Tubular Cells to Express Vasoactive and Inflammatory Mediators

Top Introduction Protein Traffic as a... Protein Uptake by Proximal... Ultrafiltered Proteins Activate... Complement as a Pathogenic... Protein Overload Activates... References

 
High concentrations of proteins (delipidated or lipid-enriched albumin, IgG and transferrin) induced in cultured proximal tubular cells a dose-dependent increase in the generation of endothelin-1 (17), a vasoconstrictor peptide deeply involved in progressive renal injury through its effect of stimulating renal cell proliferation and extracellular matrix production and its chemotactic property for monocytes (18).

Among other chemoattractants, monocyte chemoattractant protein-1 (MCP-1) and RANTES, chemokines with potent chemotactic activity for monocytes/macrophages and T lymphocytes, were upregulated in proximal tubular cells challenged with protein overload (19,20). Notably, protein secretion was polarized mainly toward the basolateral compartment of the cell, an event that could be relevant for the tubulointerstitial inflammatory response and structural injury observed in vivo in proteinuric nephropathies (2). Fractalkine, a unique chemokine that combines the property of both chemoattractant and adhesion molecules (21), was overexpressed upon albumin stimulation of proximal tubular cells, in a dose- and time-dependent manner (22). The induction of fractalkine mRNA resulted in increased synthesis of both the membrane-bound and soluble forms of fractalkine protein.

Molecular mechanisms that lead to chemokine gene induction as a consequence of enhanced protein uptake are being elucidated (20,23,24). From the most recent studies, it emerges that a candidate pathway is via NF-kB, a transcription factor of the Rel family that comprises protein homodimers or heterodimers (25,26). The prototype NF-kB is composed of p50–p65 subunits. NF-kB exists in an inactive form in the cytoplasm of cells bound to the inhibitory protein IkB. NF-kB activation by appropriate triggers, such as cytokines, viruses, and oxidants, promotes nuclear translocation of the DNA-binding subunits after they are released by IkB (25,26). We found that albumin and IgG caused a dose-dependent increase in NF-kB activation (p50–65 subunit) in proximal tubular cells followed by the upregulation of RANTES and MCP-1, which was fully suppressed by NF-kB inhibitors (20,24). Moreover, adenovirus-mediated gene transfer of IkB reduced overexpression of fractalkine mRNA transcript levels in albumin-overloaded proximal tubular cells, thus supporting a role of NF-kB activation in chemokine mRNA induction (22). A recent study has documented that reactive oxygen species act as second messengers in protein overload-induced NF-kB activation (24). Albumin and IgG dose-dependently elicited a rapid and sustained generation of hydrogen peroxide over time in human proximal tubular cells. The antioxidants DMTU and PDTC prevented H₂O₂ production and almost completely abolished the enhanced NF-kB activity induced by both proteins. An additional proof that H₂O₂ could activate NF-kB rests on the data that stimulation of tubular cells with exogenous H₂O₂ resulted in the activation of a NF-kB subunit pattern similar to that obtained after protein challenge (24). It is known that in other cellular systems, oxidant generation is upstream regulated by protein kinase C (PKC) (27). In protein-overloaded tubular cells, specific inhibitors of PKC prevented H₂O₂ generation and inhibited the abnormal NF-kB–DNA binding activity (24). That PKC and oxygen radical generation induced by protein overload function as critical signals for the expression of NF-kB–dependent genes derives from data of real-time PCR experiments showing that oxidant scavengers and PKC inhibitors almost completely abolished the upregulation of the MCP-1 gene induced by albumin.

Evidence that proteinuria may determine the activation of transcription factors and the overexpression of chemokines in vivo is available both for experimental and human progressive nephropathies. In rats with protein-overload proteinuria, a model with interstitial inflammation and tubular upregulation of MCP-1 and osteopontin (28), NF-kB activity was increased, being mainly localized in tubular epithelial cells (29). In rats with 5/6 nephrectomy, we found that increased urinary protein excretion over time was associated with a remarkable increase in NF-kB activity in remnant kidneys (30). Intense nuclear staining for the p50 NF-kB subunit was localized to proximal tubular cells. NF-kB activation was paralleled by upregulation of renal MCP-1 gene expression, with strong signals being detected in tubular epithelial cells and to a lesser extent in interstitial infiltrating cells. MCP-1 mRNA upregulation preceded the accumulation of monocytes/macrophages and T lymphocytes in the remnant kidney interstitium, suggesting that in this model the initial mononuclear cell recruitment may occur at least in part by MCP-1–dependent mechanisms. In other models of proteinuric nephropathies, renal MCP-1 overexpression has been shown to precede or coincide with the infiltration of mononuclear cells into the renal interstitium (28,31). Moreover, administration of a neutralizing anti–MCP-1 antibody to rats with tubulointerstitial nephritis significantly decreased macrophage infiltration, supporting the possibility that MCP-1 is functionally important in eliciting interstitial inflammatory responses (31).

If the interstitial inflammatory reaction is indeed a feature of protein overloading, then limiting the enhanced protein traffic should also limit the biologic effect of excessive tubular protein reabsorption and slow renal disease progression. The best strategy to date in experimental animals and humans to reduce protein traffic rests on angiotensin-converting enzyme (ACE) inhibitors, which additionally limit renal injury (32–38). Administration of ACE inhibitor to rats with remnant kidneys reduced urinary protein excretion, almost completely suppressed NF-kB DNA-binding activity, and reduced MCP-1 mRNA expression (30). The accumulation of mononuclear cells in the renal interstitium was also greatly limited by ACE inhibitor. Similar data were obtained in an immune model, passive Heyman nephritis (30). In fact, in rats with passive Heyman nephritis, proteinuria over time was associated with a remarkable increase in renal NF-kB activity, which was normalized by the early administration of ACE inhibitor. The decrease of NF-kB activation was associated with downregulation of MCP-1 expression and reduction of interstitial inflammation. Mezzano et al. (39) by analyzing renal biopsy specimens from patients with severe proteinuria detected NF-kB activation in tubular epithelial cells, which significantly correlated with the magnitude of proteinuria. There was a concomitant upregulation of proinflammatory chemokines MCP-1, RANTES, and osteopontin found mainly in tubular epithelial cells, with a stronger expression in patients with a progressive disease.

	Complement as a Pathogenic Component of Proteinuria

Top Introduction Protein Traffic as a... Protein Uptake by Proximal... Ultrafiltered Proteins Activate... Complement as a Pathogenic... Protein Overload Activates... References

 
Among secondary processes that lead to interstitial damage in proteinuric conditions, the activation of complement proteins in the proximal tubule has proinflammatory potential and thus a major role to play (40,41). Complement components can be filtered across the glomerular barrier, and deposits (C3, C5b-9) were found both along the luminal side and within proximal tubular cells in kidneys of rats in which the disease was induced by protein overload, renal mass ablation, and aminonucleoside (8,41,42), a pattern also observed in kidneys of patients with nonselective proteinuria. Complement-depletion studies by Matsuo’s (40,41) and Couser’s (43) groups, using acute proteinuric models of glomerular injury, provided direct evidence for deleterious effects of urinary complement components on the tubulointerstitium in a relatively short period. In rats with proteinuria of glomerular origin as a result of 5/6 renal mass ablation, we found intracellular C3 staining in proximal tubules at 7 d after surgery in a stage closely preceding the appearance of inflammation (44). C3 colocalized with IgG to the same tubules in adjacent sections. Protein accumulation in proximal tubular cells was followed by interstitial infiltrates of major histocompatability complex II–positive cells and ED-1 monocytes/macrophages that were first detectable in the peritubular interstitium at 14 d and then more evident at 30 d. More important, in double-stained sections, the infiltrating cells concentrated almost exclusively in regions containing C3-positive proximal tubules. Treatment with ACE inhibitor while preventing proteinuria limited both tubular accumulation of C3 and IgG and interstitial inflammation.

C3 is an essential component of both the classical and alternative pathways of complement activation (45). In vitro evidence is available that proximal tubular cells activate complement via the alternative pathway leading to fixation of the C5b-9 MAC neoantigen on the cell surface (46). This, in addition, was followed by cytoskeletal alterations, superoxide anion and hydrogen peroxide production, and synthesis of proinflammatory cytokines such as IL-6 and TNF- (47). Although the generation of C5b-9 on the apical surface can contribute to functional impairment of proximal tubular cells linked to proteinuria, the C3 component may have additional and independent proinflammatory actions in proteinuric settings. Actually, we found evidence of granular C3 staining in the basolateral region of proximal tubular cells of remnant kidneys, in addition to intracellular sites consistent with subapical and lysosomal compartments (44). Such reactivity together with the linear peripheral C3 staining may reflect polarized secretion of newly synthesized C3 into the interstitium, a pathway that would reinforce the role of proximal tubular cells as a trigger of tubulointerstitial injury. In vitro studies showed that proximal tubular epithelial cells synthesize complement components, including C3 (48). Moreover, exposure of human proximal tubular epithelial cells in culture to total serum proteins (49) or transferrin (50) at the apical surface upregulated C3 mRNA expression and enhanced the secretion of the protein predominantly at the basolateral site, providing in vitro evidence to suggest a role for locally synthesized complement in the process of tubulointerstitial damage.

More direct in vivo evidence for a role of complement in late stages of the disease has been provided by a recent study (51) using C6-deficient PVG rats with 5/6 nephrectomy. A marked improvement of tubulointerstitial injury and renal function with respect to normocomplementemic rats was in fact demonstrated in the remnant kidney when the ability to form C5-b9 was abrogated. It was suggested that treatment to reduce C5b-9 attack in tubular cells may slow disease progression and facilitate recovery of renal function (51).

	Protein Overload Activates Fibrogenic Pathways in Proximal Tubular Cells

Top Introduction Protein Traffic as a... Protein Uptake by Proximal... Ultrafiltered Proteins Activate... Complement as a Pathogenic... Protein Overload Activates... References

 
Interstitial fibrogenesis can be viewed as a multifactorial process mediated by a diversity of biologically active molecules, such as cytokines, growth factors, and vasoactive substances, resulting in abnormal accumulation of extracellular matrix collagen types, fibronectin, laminin, and other components. However, how progression factors can lead to fibrogenic responses is less well understood. Studies in experimental models indicate that the interstitial accumulation of myofibroblasts (52,53) and phenotypic changes of tubular epithelial cells (54–56) play major roles. In this context, there is evidence to suggest that the excess exposure of proximal tubular cells to ultrafiltered proteins can contribute to initiate and/or enhance fibrogenesis by at least two pathways. First, as implicated by the results of several studies that have been mentioned above, the proinflammatory activation of the tubular cells promotes local recruitment of macrophages and lymphocytes, which in turn via release of TGF-, PDGF, and other cytokines (57) can stimulate the transformation of interstitial cells into myofibroblasts. Furthermore, the proximal tubular epithelial cells can interact with surrounding interstitial fibroblasts directly to promote fibrogenesis via paracrine release of profibrogenic molecules. This has been suggested by the in vitro observation that proximal tubular cells, presumably by virtue of ability to synthesize PDGF-AB and TGF-1, stimulate renal cortical fibroblasts in co-culture to grow and synthesize collagen (58). That both the inflammatory cell-dependent pathway and the tubular paracrine pathway can be activated in vivo has been recently documented by evidence that in remnant kidneys of rats, after the onset of the proteinuric stage, cells expressing the myofibroblast-associated marker -smooth muscle actin (-SMA) in the interstitial areas colocalize with macrophages surrounding proximal tubular cells that were engaged in excess protein reabsorption. Importantly, the finding that TGF- mRNA was upregulated in proximal tubular cells since 14 d after surgery, in concomitance with the accumulation of the inflammatory cells and the -SMA–positive myofibroblasts, was consistent with the effective induction of a fibrogenic response by protein overreabsorption (59). Evidence of focal -SMA expression in proximal tubuli in a subsequent stage at 30 d supports the possibility that the same pathway may play a role in the epithelial-mesenchymal transformation, or transdifferentiation, of proximal tubular cells. TGF- has been shown to act as a single factor in inducing -SMA expression in proximal tubular cells in culture (60). Of major interest, high concentration of albumin did upregulate TGF-1 mRNA expression in proximal tubular cells (61). Other mediators in this response include PDGF (62) as well as endothelin-1, which was shown to activate -SMA gene expression (63). Moreover, complement components and protein-bound molecules in the ultrafiltrate, such as hepatocyte growth factor or TGF-1 itself (64), may further contribute to the induction of fibrosis in vivo. Finally, together with the concomitant inhibitory effects on excess protein accumulation and interstitial inflammatory cell infiltration, the antiproteinuric action of ACE inhibitor was associated with abrogation of abnormal TGF-1 gene expression in tubular cells and of myofibroblast formation (59). It seems likely that if the primary site of ACE inhibitor’s action were at the level of glomerular permselective barrier as suggested by several studies (65–68), then excess proteins in the ultrafiltrate act at least as a contributory factor to elicit the interstitial fibrogenic events that can be prevented by the antiproteinuric action of the drug. Importantly, the detection of abnormal -SMA–positive cells into the interstitium can be used as a morphologic predictor of progression in both experimental and human nephropathies (69–71), further indicating that the prevention of myofibroblast formation can be an instrumental step in the ACE inhibitor’s renoprotective action.

	References

Top Introduction Protein Traffic as a... Protein Uptake by Proximal... Ultrafiltered Proteins Activate... Complement as a Pathogenic... Protein Overload Activates... References

 

1. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652–659, 1982[Medline]
2. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448–1456, 1998[Free Full Text]
3. Remuzzi G: Nephropathic nature of proteinuria. Curr Opin Nephrol Hypertens 8: 655–663, 1999[CrossRef][Medline]
4. Bertani T, Zoja C, Abbate M, Rossini M, Remuzzi G: Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content. Lab Invest 60: 196–204, 1989[Medline]
5. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30: 488–496, 1986[Medline]
6. Davies DJ, Brewer DB, Hardwicke J: Urinary proteins and glomerular morphometry in protein overload proteinuria. Lab Invest 38: 232–243, 1978[Medline]
7. Weening JJ, Van Guldener C, Daha MR, Klar N, Van Der Wal A, Prins FA: The pathophysiology of protein-overload proteinuria. Am J Pathol 129: 64–73, 1987[Abstract]
8. Eddy AA: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135: 719–733, 1989[Abstract]
9. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9: 1213–1224, 1998[Abstract]
10. Verroust PJ, Kozyraki R: The roles of cubilin and megalin, two multiligand receptors, in proximal tubule function: Possible implication in the progression of renal disease. Curr Opin Nephrol Hypertens 10: 33–38, 2001[Medline]
11. Lou X, Mcquistan T, Orlando RA, Farquhar MG: GAIP, GIPC and Gi3 are concentrated in endocytic compartments of proximal tubule cells: Putative role in regulating megalin’s function. J Am Soc Nephrol 13: 918–927, 2002[Abstract/Free Full Text]
12. Brunskill NJ: Mechanisms of albumin uptake by proximal tubular cells. Am J Kidney Dis 37: S17–S20, 2001[Medline]
13. Dixon R, Brunskill NJ: Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: Implications for the pathophysiology of proteinuric states. J Am Soc Nephrol 10: 1487–1497, 1999[Abstract/Free Full Text]
14. Moestrup SK, Kozyraki R, Kristiansen M, Kaisen JH, Rasmussen HH, Brault D, Pontillon F, Goda FO, Christensen EI, Hammond TG, Verroust PJ: The intrinsic factor-vitamin B12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins. J Biol Chem 273: 5235–5242, 1998[Abstract/Free Full Text]
15. Birn H, Fyfe JC, Jacobsen C, Mounier F, Verroust PJ, Orskov H, Willnow TE, Moestrup SK, Christensen EI: Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest 105: 1353–1361, 2000[Medline]
16. Kozyraki R, Fyfe JC, Verroust PJ, Jacobsen C, Dautry-Varsat A, Gburek J, Willnow TE, Christensen EI, Moestrup SK: Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc Natl Acad Sci U S A 98: 12491–12496, 2001[Abstract/Free Full Text]
17. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco P, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 26: 934–941, 1995[Medline]
18. Benigni A: Endothelin antagonists in renal disease. Kidney Int 57: 1778–1794, 2000[CrossRef][Medline]
19. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DC: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8: 1537–1545, 1997[Abstract]
20. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kB activation. Kidney Int 53: 1608–1615, 1998[CrossRef][Medline]
21. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ: A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640–644, 1997[CrossRef][Medline]
22. Donadelli R, Zanchi C, Buelli S, Tomasoni S, Morigi M, Benigni A, Remuzzi G, Zoja C: Adenovirus-mediated gene transfer of IkBalpha reduces overexpression of fractalkine mRNA in protein overloaded proximal tubular cells [Abstract]. J Am Soc Nephrol 12: 650A, 2001
23. Wang Y, Rangan GK, Tay Y-C, Harris DCH: Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kB in proximal tubule cells. J Am Soc Nephrol 10: 1204–1213, 1999[Abstract/Free Full Text]
24. Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, Ghilardi M, Remuzzi G: Protein overload-induced NF-kB activation in proximal tubular cells requires H₂O₂ through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179–1189, 2002[Abstract/Free Full Text]
25. Barnes PJ, Karin M: Nuclear factor-kB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066–1071, 1997[Free Full Text]
26. Baldwin AS: The transcription factor NF-kB and human disease. J Clin Invest 107: 3–11, 2001[CrossRef][Medline]
27. Rahman A, Bando M, Kefer J, Anwar KN, Malik AB: Protein kinase C-activated oxidant generation in endothelial cells signals intercellular adhesion molecule-1 gene transcription. Mol Pharmacol 65: 675–683, 1999
28. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47: 1546–1557, 1995[Medline]
29. Gomez-Garre D, Largo R, Tejera N, Fortes J, Manzarbeitia F, Egido J: Activation of nuclear factor kB in tubular epithelial cells of rats with intense proteinuria: Role of angiotensin II and endothelin-1. Hypertension 37: 1171–1178, 2001[Abstract/Free Full Text]
30. Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, Remuzzi G, Zoja C: Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 36: 1226–1241, 2000[Medline]
31. Tang WW, Qi M, Warren JS, Van GY: Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 159: 870–876, 1997[Abstract]
32. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993–2000, 1986
33. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930, 1986
34. Ruiz-Ortega M, Gonzalez S, Seron D, Condom E, Bustos C, Largo R, Gonzales E, Ortiz A, Egido J: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48: 1778–1791, 1995[Medline]
35. Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29: 254–264, 1997[Medline]
36. Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G: ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis 34: 626–632, 1999[Medline]
37. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G, on behalf of Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN): Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 352: 1252–1256, 1998[CrossRef][Medline]
38. Ruggenenti P, Schieppati A, Remuzzi G: Progression, remission, regression of chronic renal diseases. Lancet 357: 1601–1608, 2001[CrossRef][Medline]
39. Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J: Tubular NF-kB and AP-1 activation in human proteinuric renal disease. Kidney Int 60: 1366–1377, 2001[CrossRef][Medline]
40. Morita Y, Nomura A, Yuzawa Y, Nishikawa K, Hotta N, Shimizu F, Matsuo S: The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J Am Soc Nephrol 8: 1363–1372, 1997[Abstract]
41. Nomura A, Morita Y, Maruyama S, Hotta N, Nadai M, Wang L, Hasegawa T, Matsuo S: Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol 151: 539–547, 1997[Abstract]
42. Nath KA, Hostetter MK, Hostetter TH: Pathophysiology of chronic tubulo-interstitial disease in rats: Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76: 667–675, 1985
43. Nangaku M, Pippin J, Couser WG: Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 10: 2323–2331, 1999[Abstract/Free Full Text]
44. Abbate M, Zoja C, Rottoli D, Corna D, Perico N, Bertani T, Remuzzi G: Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein and complement-dependent interstitial inflammation in experimental renal disease. J Am Soc Nephrol 10: 804–813, 1999[Abstract/Free Full Text]
45. Zhou W, Marsh JE, Sacks SH: Intrarenal synthesis of complement. Kidney Int 59: 1227–1235, 2001[CrossRef][Medline]
46. Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G: Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 45: 451–460, 1994[Medline]
47. David S, Biancone L, Caserta C, Bussolati B, Cambi V, Camussi G: Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 12: 51–56, 1997[Abstract/Free Full Text]
48. Brooimans RA, Stegmann APA, van Dorp WT, van der Ark AAJ, van der Woude FJ, van Es LA, Daha MR: Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88: 379–384, 1991
49. Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH: Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. J Am Soc Nephrol 10: 69–76, 1999[Abstract/Free Full Text]
50. Tang S, Neng Lai K, Mao Chan T, Lan HY, Ho SK, Sacks SH: Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Am J Kidney Dis 37: 94–103, 2001[Medline]
51. Nangaku M, Pippin J, Couser WG: C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 13: 928–936, 2002[Abstract/Free Full Text]
52. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-beta1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103–111, 1993[Abstract/Free Full Text]
53. Muchaneta-Kubara EC, El-Nahas M: Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 12: 904–915, 1997[Abstract/Free Full Text]
54. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130: 393–405, 1995[Abstract/Free Full Text]
55. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY: Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38: 761–769, 2001[Medline]
56. Zeisberg M, Strutz F, Muller GA: Renal fibrosis: An update. Curr Opin Nephrol Hypertens 10: 315–320, 2001[CrossRef][Medline]
57. Eddy AA: Role of cellular infiltrates in response to proteinuria. Am J Kidney Dis 37 [Suppl 2]: S25–S29, 2001[Medline]
58. Johnson DW, Saunders HJ, Baxter RC, Field MJ, Pollock CA: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 54: 747–757, 1998[CrossRef][Medline]
59. Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, Remuzzi G: Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int 61: 2066–2077, 2002[CrossRef][Medline]
60. Okada H, Danoff TM, Kalluri R, Neilson EG: Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273: F563–F574, 1997
61. Yard BA, Chorianopoulos E, Herr D, van der Woude FJ: Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant 16: 1769–1775, 2001[Abstract/Free Full Text]
62. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS: Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148: 1169–1180, 1996[Abstract]
63. Andrawis NS, Wang E, Abernethy DR: Endothelin-1 induces an increase in total protein synthesis and expression of the smooth muscle alpha-actin gene in vascular smooth muscle cells. Life Sci 59: 523–528, 1996[CrossRef][Medline]
64. Wang S-N, LaPage J, Hirschberg R: Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57: 1002–1014, 2000[CrossRef][Medline]
65. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541–549, 1990
66. Remuzzi A, Monaci N, Bonassi ME, Corna D, Zoja C, Mohammed EI, Remuzzi G: Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive Heymann nephritis. Lab Invest 79: 1501–1510, 1999[Medline]
67. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12: 941–948, 2001[Abstract/Free Full Text]
68. Wapstra FH, Navis GJ, van Goor H, van den Born J, Berden JHM, de Jong PE, de Zeeuw D: ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy. Exp Nephrol 9: 21–27, 2001[CrossRef][Medline]
69. Goumenos D, Tsomi K, Iatrou C, Oldroyd S, Sungur A, Papaioannides D, Moustakas G, Ziroyannis P, Mountokalakis T, El-Nahas M: Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 13: 1652–1661, 1998[Abstract/Free Full Text]
70. Pilmore HL, Painter DM, Bishop GA, McCaughan GW, Eris JM: Early up-regulation of macrophages and myofibroblasts. Transplantation 69: 2658–2669, 2000[CrossRef][Medline]
71. Mezzano SA, Droguett MA, Burgos ME, Ardiles LG, Aros CA, Caorsi I, Egido J: Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 57: 147–158, 2000[CrossRef][Medline]

This article has been cited by other articles:

				V. Pollack, R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1714 - F1726. [Abstract] [Full Text] [PDF]

				M. R. Garrett, W. T. Gunning, T. Radecki, and A. Richard Dissection of a genetic locus influencing renal function in the rat and its concordance with kidney disease loci on human chromosome 1q21 Physiol Genomics, August 20, 2007; 30(3): 322 - 334. [Abstract] [Full Text] [PDF]

				A. Djamali Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts Am J Physiol Renal Physiol, August 1, 2007; 293(2): F445 - F455. [Abstract] [Full Text] [PDF]

				C. Caruso-Neves, A. A. S. Pinheiro, H. Cai, J. Souza-Menezes, and W. B. Guggino PKB and megalin determine the survival or death of renal proximal tubule cells PNAS, December 5, 2006; 103(49): 18810 - 18815. [Abstract] [Full Text] [PDF]

				P. N. Cunningham and R. J. Quigg Contrasting Roles of Complement Activation and Its Regulation in Membranous Nephropathy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1214 - 1222. [Abstract] [Full Text] [PDF]

				A. Benigni, D. Corna, C. Zoja, L. Longaretti, E. Gagliardini, N. Perico, T. M. Coffman, and G. Remuzzi Targeted Deletion of Angiotensin II Type 1A Receptor Does not Protect Mice from Progressive Nephropathy of Overload Proteinuria J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2666 - 2674. [Abstract] [Full Text] [PDF]

				W. A. Wilmer, B. H. Rovin, C. J. Hebert, S. V. Rao, K. Kumor, and L. A. Hebert Management of Glomerular Proteinuria: A Commentary J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3217 - 3232. [Abstract] [Full Text] [PDF]

				R. Donadelli, C. Zanchi, M. Morigi, S. Buelli, C. Batani, S. Tomasoni, D. Corna, D. Rottoli, A. Benigni, M. Abbate, et al. Protein Overload Induces Fractalkine Upregulation in Proximal Tubular Cells through Nuclear Factor {kappa}B- and p38 Mitogen-Activated Protein Kinase-Dependent Pathways J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2436 - 2446. [Abstract] [Full Text] [PDF]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zoja, C. Articles by Remuzzi, G. Search for Related Content PubMed PubMed Citation Articles by Zoja, C. Articles by Remuzzi, G.